COMPASS Pathways plc(CMPS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CMPS COMPASS Pathways plc

Trading 06-23 14:38:37 EDT

12.70

+0.07

+0.55%

High13.00	Low12.20	Vol1.69M
Open12.20	D1 Closing12.63	Amplitude6.33%
Mkt Cap1.71B	Tradable Cap1.30B	Total Shares135.00M
T/O21.41M	T/O Rate1.65%	Tradable Shares102.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CMPS","market":"US","secType":"STK","nameCN":"COMPASS Pathways plc","latestPrice":12.7,"timestamp":1782239916794,"preClose":12.63,"halted":0,"volume":1685202,"delay":0,"changeRate":0.005542359461599248,"floatShares":102000000,"shares":135000000,"eps":-3.080125,"marketStatus":"Trading","change":0.07,"latestTime":"06-23 14:38:37 EDT","open":12.2,"high":13,"low":12.2,"amount":21408472.538004,"amplitude":0.063341,"askPrice":12.7,"askSize":295,"bidPrice":12.69,"bidSize":576,"shortable":3,"etf":0,"ttmEps":-3.080125,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1782244800000},"marketStatusCode":2,"adr":0,"adrRate":1,"listingDate":1600401600000,"exchange":"NASDAQ","adjPreClose":12.63,"preHourTrading":{"tag":"盘前","latestPrice":12.29,"preClose":12.63,"latestTime":"09:27 EDT","volume":14129,"amount":171314.944482,"timestamp":1782221258535,"change":-0.34,"changeRate":-0.02692,"amplitude":0.058591},"postHourTrading":{"tag":"盘后","latestPrice":12.51,"preClose":12.63,"latestTime":"19:56 EDT","volume":32479,"amount":409469.4015,"timestamp":1782172606774,"change":-0.12,"changeRate":-0.009501,"amplitude":0.031686},"volumeRatio":0.809832,"impliedVol":1.0083,"impliedVolPercentile":0.4263},"requestUrl":"/m/hq/s/CMPS/wiki","defaultTab":"wiki","newsList":[{"id":"2645029776","title":"Definium's LSD-based depression pill delivers strong late-stage results, shares surge","url":"https://stock-news.laohu8.com/highlight/detail?id=2645029776","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645029776?lang=en_us&edition=fundamental","pubTime":"2026-06-22 19:11","pubTimestamp":1782126682,"startTime":"0","endTime":"0","summary":"UPDATE 2-Definium's LSD-based depression pill delivers strong late-stage results, shares surgeUpdates share movement, adds analyst comment 6 and 7, background throughoutBy Kamal Choudhury","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nL4N42U0S5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1496350502.SGD","LU1778281490.HKD","LU1551013425.SGD","LU2896262040.SGD","BK4585","LU1057294990.SGD","LU0070217475.USD","SG9999001176.SGD","LU0432979614.USD","CMPS","LU1244550577.SGD","LU2471134952.CNY","LU2756315664.SGD","DFTX","SUPN","IE0001KFT4U8.USD","IE00B4R5TH58.HKD","LU0053666078.USD","LU0683600562.USD","LU2430703251.USD","LU1894683264.USD","LU1121112475.USD","LU1551013342.USD","LU2456880835.USD","LU0345769631.USD","AXSM","BK4550","IE00BN8TJ469.HKD","LU1074936037.SGD","LU0943347566.SGD","SG9999013999.USD","LU1043141123.HKD","LU1244550221.USD","IE00BKVL7J92.USD","LU1929549753.HKD","LU0210528500.USD","LU2417539215.USD","LU1162221912.USD","JNJ","LU0122379950.USD","LU1244550494.USD","LU1914381329.SGD","SGXZ57979304.SGD","LU0466842654.USD","BK4504","LU1196500208.SGD","LU2236285917.USD","IE0002270589.USD","LU0689626769.HKD","LU0124676726.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643768391","title":"Unusually active option classes on open June 16th","url":"https://stock-news.laohu8.com/highlight/detail?id=2643768391","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643768391?lang=en_us&edition=fundamental","pubTime":"2026-06-16 21:40","pubTimestamp":1781617224,"startTime":"0","endTime":"0","summary":"Unusual total active option classes on open include: Rackspace Technology (RXT), COMPASS Pathways PLC (CMPS), Tradr 2X Long SNDK Daily ETF (SNXX), ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/unusually-active-option-classes-on-open-june-16th-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/unusually-active-option-classes-on-open-june-16th-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4588","SNXX","CMPS","BK4608","SNDU","FDN","BK4585","BK4116","BK4550","RXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641143286","title":"Compass Pathways targets late 2027 approval for treatment-resistant depression psychedelic therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2641143286","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641143286?lang=en_us&edition=fundamental","pubTime":"2026-06-05 21:21","pubTimestamp":1780665663,"startTime":"0","endTime":"0","summary":"Bellevue Group highlighted Roche’s push into AI-driven R&D; giredestrant flagged as a potential multi-billion-dollar breast cancer drug.BridgeBio’s Attruby described as tracking toward multi-billion-dollar potential; management targets profitability by 2027, cites USD 8 billion combined peak sales.Cogent Biosciences faces two late-2026 FDA decisions for bezuclastinib; approval could shift it from development-stage to commercial operations.Compass Pathways expects to file in Q4 for treatment-resistant depression; potential approval late 2027, DEA scheduling expected 2-4 months later.Inventiva expects Phase III lanifibranor readout in Q4; management focuses on fibrosis reversal, with upside tied to clinical data.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, invest","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nNDL2vvDx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","CMPS","COGT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641114226","title":"Compass Pathways grants 157,000 inducement stock options at USD 14.19 per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2641114226","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641114226?lang=en_us&edition=fundamental","pubTime":"2026-06-05 18:30","pubTimestamp":1780655431,"startTime":"0","endTime":"0","summary":"Compass Pathways rolled out equity inducement grants on June 1, 2026 for 17 newly hired non-executive employees under its 2026 Inducement Plan.Issued options covering 157,000 shares at an exercise price of USD 14.19, matching the ADS close on the grant date.Options vest over four years: 25% on the first anniversary, then monthly over the next three years, subject to continued employment.Granted restricted share units or UK nominal cost options covering 74,700 shares, vesting in four equal annual installments.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nNDL92SDbY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641511447","title":"Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2641511447","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641511447?lang=en_us&edition=fundamental","pubTime":"2026-06-05 18:30","pubTimestamp":1780655400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nTUA9NCSYX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640152127","title":"Hypha Labs flags cannabis-like growth pattern emerging in psychedelic industry","url":"https://stock-news.laohu8.com/highlight/detail?id=2640152127","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640152127?lang=en_us&edition=fundamental","pubTime":"2026-06-04 20:00","pubTimestamp":1780574423,"startTime":"0","endTime":"0","summary":"Hypha Labs published market analysis flagging parallels between psychedelics now and early legal cannabis market expansion.Focus on state-level reform, rising public acceptance, expanding clinical validation, increasing institutional capital as key industry catalysts.Highlights psilocybin access programs, decriminalization moves, late-stage trials as momentum signals for commercialization.Notes COMPASS Pathways market capitalization approaching $2 billion as a benchmark for sector valuation growth.Frames production infrastructure as a potential value pool, citing its patent-pending bioreactor and MicroPearls platform for scalable compound output.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDL43DzJL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4191","FUNI","CMPS","BK4196","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166367752","title":"Stock Track | COMPASS Pathways Soars 9.84% Intraday on Board Appointment Signaling Stronger Commercialization Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=1166367752","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166367752?lang=en_us&edition=fundamental","pubTime":"2026-06-02 00:41","pubTimestamp":1780332072,"startTime":"0","endTime":"0","summary":"COMPASS Pathways plc's stock surged 9.84% during intraday trading on Monday, following the announcement that Kathleen Tregoning has been elected to its Board of Directors.The significant price...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640794937","title":"Is COMPASS Pathways (CMPS) Recasting Its Commercialization Strategy With Kathleen Tregoning’s Board Appointment?","url":"https://stock-news.laohu8.com/highlight/detail?id=2640794937","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640794937?lang=en_us&edition=fundamental","pubTime":"2026-06-01 17:23","pubTimestamp":1780305802,"startTime":"0","endTime":"0","summary":"COMPASS Pathways plc recently announced that Kathleen Tregoning has been elected to its Board of Directors, with plans for her to serve on both the Compensation and Leadership Development Committee and the Nominating and Corporate Governance Committee.\nHer background leading corporate affairs and commercial strategy at Cerevel Therapeutics, Sanofi and Biogen, combined with deep health policy experience in the U.S. Congress, adds industry, regulatory and commercialization expertise that could...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cmps/compass-pathways/news/is-compass-pathways-cmps-recasting-its-commercialization-str","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cmps/compass-pathways/news/is-compass-pathways-cmps-recasting-its-commercialization-str","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4023","AI","BK4528","BK4587","BK4139","AIPO","AIYY","CMPS","BK4585","BK4588","CHAT","BK4543","AGIX","ARTY","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639708536","title":"Compass Pathways files Form 3 initial beneficial ownership statement for director Kathleen Tregoning","url":"https://stock-news.laohu8.com/highlight/detail?id=2639708536","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639708536?lang=en_us&edition=fundamental","pubTime":"2026-05-30 05:09","pubTimestamp":1780088971,"startTime":"0","endTime":"0","summary":"Compass Pathways filed an initial Form 3 for director Kathleen Tregoning dated May 27, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Compass Pathways plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 29, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDL3LDPW5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMPS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639167455","title":"COMPASS Pathways PLC call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2639167455","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639167455?lang=en_us&edition=fundamental","pubTime":"2026-05-30 02:31","pubTimestamp":1780079463,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in COMPASS Pathways (CMPS) PLC with 12,790 calls trading, 3x expected, and implied vol increasing almost 3 points to 8...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/compass-pathways-plc-call-volume-above-normal-and-directionally-bullish-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/compass-pathways-plc-call-volume-above-normal-and-directionally-bullish-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CMPS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638627546","title":"Compass Pathways shareholders re-elect Justin Gover as director at AGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2638627546","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638627546?lang=en_us&edition=fundamental","pubTime":"2026-05-28 18:44","pubTimestamp":1779965040,"startTime":"0","endTime":"0","summary":"Compass Pathways held its annual general meeting on May 27, 2026.Shareholders accepted the 2025 U.K. statutory annual accounts and report, noting the board did not recommend a dividend for 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Compass Pathways plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 28, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nNDLp8dp6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638662632","title":"Compass Pathways elects Kathleen Tregoning to board of directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2638662632","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638662632?lang=en_us&edition=fundamental","pubTime":"2026-05-28 18:30","pubTimestamp":1779964255,"startTime":"0","endTime":"0","summary":"Compass Pathways elected Kathleen Tregoning to its board at the annual shareholder meeting.Tregoning is set to join the compensation and leadership development committee, plus the nominating and corporate governance committee.She was chief corporate affairs officer, head of commercial strategy at Cerevel Therapeutics through its 2024 acquisition by AbbVie.Earlier roles include EVP of external affairs at Sanofi, plus more than a decade in corporate affairs at Biogen.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nNDL9Prqrk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1551013342.USD","LU0965509283.SGD","ABBV","IE00BLSP4452.SGD","LU0256863811.USD","IE00BBT3K403.USD","LU1074936037.SGD","LU0158827948.USD","LU2087621335.USD","LU2357627491.SGD","IE00B19Z9P08.USD","BK4581","IE00B4R5TH58.HKD","LU0472753341.HKD","LU0689626769.HKD","LU2237443465.HKD","IE0004445239.USD","IE00B3PB1722.GBP","IE00BN8TJ469.HKD","LU0861579265.USD","LU0965509101.SGD","LU1037948897.HKD","SG9999003800.SGD","LU1934455194.USD","LU0122379950.USD","LU0661504455.SGD","LU1732800096.USD","SG9999001440.SGD","LU1496350171.SGD","IE00BLSP4239.USD","LU1037948541.HKD","LU0795875169.SGD","LU1551013425.SGD","LU0203345920.USD","LU2089283258.USD","BK4559","LU2468319806.SGD","LU1244550221.USD","BK4550","CMPS","LU1839511570.USD","LU0859254822.USD","BK4534","BIIB","LU1267930573.SGD","LU2129689431.USD","LU0029864427.USD","LU1267930490.SGD","LU0320765646.SGD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638566256","title":"Compass Pathways Elects Kathleen Tregoning to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2638566256","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638566256?lang=en_us&edition=fundamental","pubTime":"2026-05-28 18:30","pubTimestamp":1779964200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nTUA7F2TQL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638515515","title":"Compass Pathways to join Jefferies Global Healthcare Conference fireside chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2638515515","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638515515?lang=en_us&edition=fundamental","pubTime":"2026-05-26 18:30","pubTimestamp":1779791420,"startTime":"0","endTime":"0","summary":"Compass Pathways management will attend the Jefferies Global Healthcare Conference on June 3, 2026.Management is scheduled to join a fireside chat at 12:45 p.m. ET.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nNDL46Bp4F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMPS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635373630","title":"Compass Pathways Is Maintained at Buy by Maxim Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2635373630","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635373630?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:01","pubTimestamp":1778875260,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CMPS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 15, 2026 16:01 ET (20:01 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635722433","title":"Why COMPASS Pathways (CMPS) Is Up 13.1% After FDA Fast-Track Moves For COMP360 Profit Shift","url":"https://stock-news.laohu8.com/highlight/detail?id=2635722433","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635722433?lang=en_us&edition=fundamental","pubTime":"2026-05-15 06:43","pubTimestamp":1778798614,"startTime":"0","endTime":"0","summary":"In the first quarter of 2026, COMPASS Pathways reported net income of US$91.2 million, or US$0.71 per share, and announced U.S. FDA acceptance of a rolling New Drug Application and a National Priority Review Voucher for its COMP360 psilocybin therapy in treatment-resistant depression.\nThis combination of an accounting-driven swing to profitability and accelerated regulatory review for COMP360 marks a key moment for COMPASS Pathways’ shift from pure R&D focus toward potential commercial...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cmps/compass-pathways/news/why-compass-pathways-cmps-is-up-131-after-fda-fast-track-mov","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cmps/compass-pathways/news/why-compass-pathways-cmps-is-up-131-after-fda-fast-track-mov","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CMPS","BK4588","BK4139","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635446007","title":"Compass Pathways Is Maintained at Overweight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2635446007","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635446007?lang=en_us&edition=fundamental","pubTime":"2026-05-15 00:55","pubTimestamp":1778777700,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CMPS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 14, 2026 12:55 ET (16:55 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635441267","title":"Compass Pathways price target raised to $17 from $16 at Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2635441267","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635441267?lang=en_us&edition=fundamental","pubTime":"2026-05-15 00:52","pubTimestamp":1778777546,"startTime":"0","endTime":"0","summary":"Morgan Stanley analyst Judah Frommer raised the firm’s price target on Compass Pathways (CMPS) to $17 from $16 and keeps an Overweight rating on th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/compass-pathways-price-target-raised-to-17-from-16-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/compass-pathways-price-target-raised-to-17-from-16-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2023251221.USD","BK4516","LU0320765646.SGD","LU1244550494.USD","LU0225283273.USD","LU2111349929.HKD","LU1720051017.SGD","LU1244550577.SGD","LU2357305700.SGD","LU0528227936.USD","LU1363072403.SGD","LU1732799900.SGD","LU0795875169.SGD","BK4588","LU0912757837.SGD","LU1074936037.SGD","LU0557290698.USD","LU2347655156.SGD","LU1064131342.USD","LU1548497426.USD","LU0971096721.USD","LU2089283258.USD","LU0267386448.USD","LU2089284900.SGD","BK4127","LU0314104364.USD","CMPS","BK4139","LU2133065610.SGD","LU1989772840.SGD","LU1732800096.USD","LU1162221912.USD","LU1988902786.USD","IE00BZ1G4Q59.USD","LU2271345857.HKD","BK4504","BK4534","LU0158827781.USD","LU1791710582.SGD","LU0158827948.USD","LU1720051108.HKD","IE00BKVL7J92.USD","LU0098860793.USD","LU0234570918.USD","LU2028103732.USD","BK4581","LU0106261372.USD","LU1244550221.USD","LU0106831901.USD","LU0006306889.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635749599","title":"Jefferies Remains a Buy on COMPASS Pathways (CMPS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635749599","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635749599?lang=en_us&edition=fundamental","pubTime":"2026-05-14 23:15","pubTimestamp":1778771743,"startTime":"0","endTime":"0","summary":"Jefferies analyst Andrew Tsai maintained a Buy rating on COMPASS Pathways today and set a price target of $18.00. According to TipRanks, Tsai is a ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jefferies-remains-a-buy-on-compass-pathways-cmps-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jefferies-remains-a-buy-on-compass-pathways-cmps-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635771476","title":"RBC Raises Price Target on COMPASS Pathways to $22 From $21, Keeps Outperform, Speculative Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2635771476","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635771476?lang=en_us&edition=fundamental","pubTime":"2026-05-14 19:58","pubTimestamp":1778759883,"startTime":"0","endTime":"0","summary":"COMPASS Pathways (CMPS) has an average rating of buy and mean price target of $21.43, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ba","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CMPS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.compasspathways.com","stockEarnings":[{"period":"1week","weight":0.0712},{"period":"1month","weight":0.0694},{"period":"3month","weight":1.4195},{"period":"6month","weight":0.8451},{"period":"1year","weight":1.7279},{"period":"ytd","weight":0.8304}],"compareEarnings":[{"period":"1week","weight":-0.0138},{"period":"1month","weight":-0.0017},{"period":"3month","weight":0.1396},{"period":"6month","weight":0.0782},{"period":"1year","weight":0.2526},{"period":"ytd","weight":0.0916}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.053854},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.067409},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.124725},{"month":4,"riseRate":0.5,"avgChangeRate":0.092687},{"month":5,"riseRate":0.5,"avgChangeRate":0.037097},{"month":6,"riseRate":0.5,"avgChangeRate":-0.020602},{"month":7,"riseRate":0.8,"avgChangeRate":0.262657},{"month":8,"riseRate":0.4,"avgChangeRate":-0.005792},{"month":9,"riseRate":0.2,"avgChangeRate":-0.10118},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.009194},{"month":11,"riseRate":0.333333,"avgChangeRate":0.034765},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.01163}],"exchange":"NASDAQ","name":"COMPASS Pathways plc","nameEN":"COMPASS Pathways plc","securityTypeName":"DR","adrRate":"1:1"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"COMPASS Pathways plc(CMPS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest COMPASS Pathways plc(CMPS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"COMPASS Pathways plc,CMPS,COMPASS Pathways plc股票,COMPASS Pathways plc股票老虎,COMPASS Pathways plc股票老虎国际,COMPASS Pathways plc行情,COMPASS Pathways plc股票行情,COMPASS Pathways plc股价,COMPASS Pathways plc股市,COMPASS Pathways plc股票价格,COMPASS Pathways plc股票交易,COMPASS Pathways plc股票购买,COMPASS Pathways plc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"COMPASS Pathways plc(CMPS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest COMPASS Pathways plc(CMPS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}